PsO Disease Information
PsO affects between 0.2% to 4.8% of the Canadian population.2
PsO:2,3
can occur at any age but generally begins in young to middle-aged adults.
characterized by dry, itchy, raised skin patches (plaques) covered with scales.
plaques may occur in a few small areas or may cover a large part of the body.
Learn more about COSENTYX® and PsO
Consult the Product Monograph at www.novartis.ca/CosentyxMonograph for contraindications, warnings, precautions, adverse reactions, interactions, dosing, and conditions of clinical use. The Product Monograph is also available through our medical department. Call us at 1-800-363-8883.
References
COSENTYX® Product Monograph. Novartis Pharmaceuticals Canada Inc.
Canadian Skin Patient Alliance (CSPA). Psoriasis. Available at: https://www.canadianskin.ca/psoriasis (accessed Jan. 10, 2024).
Mayo Clinic. Psoriasis symptoms and causes. Available at: https://www.mayoclinic.org/diseases-conditions/psoriasis/symptoms-causes/syc-20355840 (accessed Jan. 10, 2024).
COSENTYX and SensoReady are registered trademarks.
Product Monograph available on request
431035E
© Novartis Pharmaceuticals Canada Inc. January 2025
Related content
Patient Support Program
Patient Support Program
Get tailored support for you and your COSENTYX® patients.
Resources
Resources
Access COSENTYX® resources for your patients and your practice.